<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Shiga toxin-producing Escherichia coli: Microbiology, pathogenesis, epidemiology, and prevention</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Shiga toxin-producing Escherichia coli: Microbiology, pathogenesis, epidemiology, and prevention</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Shiga toxin-producing Escherichia coli: Microbiology, pathogenesis, epidemiology, and prevention</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Lori R Holtz, MD, MSPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Phillip I Tarr, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephen B Calderwood, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sheldon L Kaplan, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 03, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H293959535"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span><em>Escherichia coli</em> that contain one or more genes encoding Shiga toxins are important human pathogens. They first came to medical attention in 1983 with two nearly simultaneous reports, one of which identified <em>E. coli</em> O157:H7 in the stools of patients with bloody diarrhea who had been exposed to undercooked hamburgers [<a href="#rid1">1</a>], and the other identified <em>E. coli</em> O157:H7 and Shiga toxin-producing <em>E. coli</em> (STEC) belonging to other serotypes in the stools of children with hemolytic uremic syndrome [<a href="#rid2">2</a>]. </p><p>The microbiology, pathogenesis, epidemiology, and prevention of STEC infections will be reviewed here. The clinical manifestations, diagnosis (including clinical diagnostic microbiology), and treatment of STEC infections are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2714.html" rel="external">"Shiga toxin-producing Escherichia coli: Clinical manifestations, diagnosis, and treatment"</a>.)</p><p class="headingAnchor" id="H884059531"><span class="h1">MICROBIOLOGY</span></p><p class="headingAnchor" id="H1758792475"><span class="h2">Nomenclature</span><span class="headingEndMark"> — </span>We use the term STEC to refer to the <em>E. coli</em> that produce Shiga toxins [<a href="#rid3">3</a>].</p><p>Shiga toxin is the principal extracellular cytotoxin of <em>Shigella dysenteriae </em>serotype 1. <em>E. coli</em> Shiga toxins belong to two families:</p><p class="bulletIndent1"><span class="glyph">●</span>Shiga toxin 1 (and its allelic variants) are nearly identical to Shiga toxin of <em>S. dysenteriae</em>.</p><p class="bulletIndent1"><span class="glyph">●</span>Shiga toxin 2 (and its variants) have approximately 57 percent homology to Shiga toxin 1.</p><p></p><p>Shiga toxins consist of a pentameric (B) subunit, which binds to globotriaosylceramide on the surface of eukaryotic cells, and an enzymatically active A subunit, which is a ribotoxin that inhibits protein synthesis.</p><p>STEC are also variably termed verotoxigenic <em>E. coli</em> (VTEC), because of the cell line (Vero) that was used to first demonstrate their cytotoxicity, and enterohemorrhagic <em>E. coli</em> (EHEC), because they often cause bloody diarrhea. Shiga toxins are synonymous with verotoxins. The terms Shiga-like toxins and Shiga-like toxin-produci<em>ng E. coli</em> have fallen into disuse.</p><p>STEC nomenclature has been confusing and problematic. As an example, STEC that produce Shiga toxin 1 but do not produce Shiga toxin 2 rarely cause bloody diarrhea, so "enterohemorrhagic" is an inaccurate term for such organisms. </p><p>"STEC" is also a confusing term because providers sometimes interpret the detection of Shiga toxin to mean that a patient is infected with <em>Shigella</em> [<a href="#rid4">4</a>]. <em>Shigella dysenteriae</em> serotype 1, which is almost never detected in the United States, and rare isolates of <em>Shigella sonnei </em>and <em>Shigella flexneri</em> are the only <em>Shigella</em> species that synthesize Shiga toxin [<a href="#rid5">5-8</a>]. (See  <a class="medical medical_review" href="/z/d/html/2718.html" rel="external">"Shigella infection: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H1166976902"><span class="h2">Serotypes</span><span class="headingEndMark"> — </span><em>E. coli</em> strains and lineages are classified by their O and H antigens. The O antigen is defined serologically and determined by the repeating polysaccharide chains that are part of the lipopolysaccharide (LPS) embedded in the outer leaflet of the outer membrane. The H antigen is defined serologically by the antigenic specificity of the bacterial flagellum. Members of a clone of bacteria that express the same O antigen are described as a serogroup. When the serogroup and the H (flagellar) antigen are mentioned in unison, the designation becomes a serotype. <em>E. coli</em> O157:H7 refers to a serotype, and <em>E. coli</em> O157 refers to a serogroup.</p><p><em>E. coli</em> O157:H7 is the most commonly studied serotype of STEC. This serotype does not ferment <a class="drug drug_general" data-topicid="9940" href="/z/d/drug information/9940.html" rel="external">sorbitol</a> when grown on agar plates containing sorbitol as a carbon source. This easily detectable property facilitated an early understanding of the epidemiology and spectrum of infections caused by strains of this serotype. A number of other <em>E. coli </em>serogroups produce Shiga toxin ("non-O157 STEC"). These non-O157 STEC have been identified less frequently because few possess a phenotype as distinctive as the inability to ferment sorbitol on agar plates. Newer diagnostic microbiology technology increasingly detects non-O157 STEC infections, and knowledge of the illnesses they cause is growing. These STEC are associated with a broader spectrum of illness than <em>E. coli</em> O157:H7 and are usually less severe (<a class="graphic graphic_table graphicRef120224" href="/z/d/graphic/120224.html" rel="external">table 1</a>). <em>E. coli</em> O157:H7 remains, nevertheless, a leading serotype worldwide, and, in general, causes more severe disease than non-O157 STEC, as discussed elsewhere. (See <a class="local">'Shiga toxin type'</a> below.)</p><p>One STEC of note is the sorbitol-fermenting (SF), nonmotile <em>E. coli</em> O157:NM (also called <em>E. coli</em> O157: H negative), a serotype that is largely confined to Germany and the Czech Republic and is closely related phylogenetically to sorbitol-nonfermenting <em>E. coli</em> O157:H7 [<a href="#rid9">9</a>]. Technically, it is an <em>E. coli</em> O157 STEC, though is not detected on sorbitol-MacConkey agar. SF <em>E. coli</em> O157:NM is at least as virulent as <em>E. coli</em> O157:H7 in terms of hemolytic uremic syndrome (HUS) risk. </p><p>Other non-O157 STEC isolated from humans are much less closely related to <em>E. coli</em> O157:H7. The major non-O157 STEC that cause human disease belong to <em>E. coli</em> serogroups that express the lipopolysaccharide side chains O26, O45, O92, O103, O111, O113, O121, and O145. Many additional non-O157:H7 STEC are found in food and in the environment and have minimal or no association with human disease.</p><p>As discussed, the predominance of <em>E. coli</em> O157:H7 partly relates to the ease with which this serotype can be detected on <a class="drug drug_general" data-topicid="9940" href="/z/d/drug information/9940.html" rel="external">sorbitol</a> MacConkey (with or without supplementation with <a class="drug drug_general" data-topicid="9216" href="/z/d/drug information/9216.html" rel="external">cefixime</a> and tellurite) or other differentiating and selective agar. Techniques used to detect non-O157:H7 STEC serotypes include toxin enzyme immunoassays of overnight broth cultures of stools, nucleic acid amplification of Shiga toxin genes directly from stool, broth, or isolated colonies [<a href="#rid10">10</a>], and chromogenic and selective and differentiating agars [<a href="#rid11">11</a>]. Methods for detecting STEC in clinical situations and guidance for interpreting results, which are critical components of patient care, are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2714.html" rel="external">"Shiga toxin-producing Escherichia coli: Clinical manifestations, diagnosis, and treatment", section on 'Microbiologic diagnosis'</a>.)</p><p>For <em>E. coli</em> O157:H7 and non-O157:H7 STEC alike, identifying the presence of the H antigen is not needed for clinical care. Note also that a small number of sorbitol-nonfermenting <em>E. coli</em> O157 are nonmotile [<a href="#rid12">12</a>], but these organisms can be considered identical for clinical and diagnostic purposes to classic sorbitol-nonfermenting <em>E. coli</em> O157:H7.</p><p class="headingAnchor" id="H3178378227"><span class="h2">Shiga toxin type</span><span class="headingEndMark"> — </span>STEC infections fall into two clinically relevant categories: </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infections caused by </strong><strong><em>E. coli</em></strong><strong> that contain a gene encoding Shiga toxin 2 (with or without a gene encoding Shiga toxin 1)</strong> – STEC that contain the gene encoding Shiga toxin 2 are often recovered from patients with bloody diarrhea. They can also cause HUS independent of serogroup. Hence, bloody diarrhea is a reasonable surrogate indicator of the presence of an STEC that contains a gene encoding Shiga toxin 2.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infections caused by </strong><strong><em>E. coli</em></strong><strong> that contain a gene encoding Shiga toxin 1 but do not contain a gene encoding Shiga toxin 2</strong> – These usually do not cause bloody diarrhea or HUS, but there are exceptions [<a href="#rid13">13</a>].</p><p></p><p>Almost all <em>E. coli</em> O157:H7 contain a gene encoding Shiga toxin 2; about two-thirds of this serotype also contain a gene encoding Shiga toxin 1 [<a href="#rid14">14,15</a>]. Hence, all <em>E. coli</em> O157:H7 isolated from humans should be assumed to possess a gene encoding Shiga toxin 2 and be highly pathogenic. Interestingly, <em>E. coli</em> O157:H7 that contain the genes encoding both Shiga toxin 1 and Shiga toxin 2 are associated with a lower risk of developing HUS than those that contain only Shiga toxin 2 [<a href="#rid14">14,16-18</a>]. However, the difference in risk between a STEC is not sufficient to make a clinical decision that a patient will not develop HUS if infected with a STEC that produces both Shiga toxins.</p><p>In contrast, non-O157:H7 STEC isolated from humans usually contain a gene encoding Shiga toxin 1; only a subset contains a gene encoding Shiga toxin 2. Shiga toxin 2-producing non-O157:H7 STEC are more pathogenic than the larger group of non-O157:H7 STEC that do not contain this gene. The illnesses these Shiga toxin 2–producing <em>E. coli</em> cause are as serious as those caused by <em>E. coli</em> O157:H7. An appreciable subset of non-O157:H7 STEC infections involve multiple enteric pathogens [<a href="#rid19">19</a>].</p><p>We use the term "high-risk STEC" to refer to any <em>E. coli</em> that contains a gene encoding Shiga toxin 2, including all <em>E. coli</em> O157:H7, sorbitol-fermenting <em>E. coli</em> O157:NM, and <em>E. coli</em> of other serogroups that contain a gene encoding Shiga toxin 2, given their association with severe human disease, especially HUS.</p><p class="headingAnchor" id="H365559434"><span class="h1">PATHOGENESIS</span></p><p class="headingAnchor" id="H2984264470"><span class="h2">Infectious dose</span><span class="headingEndMark"> — </span>The infectious dose of <em>E. coli</em> O157:H7 is low. One study has estimated that as few as 10 viable <em>E. coli </em>O157:H7 can cause disease in humans [<a href="#rid20">20</a>]. </p><p class="headingAnchor" id="H3568446510"><span class="h2">Toxin production</span><span class="headingEndMark"> — </span>The cardinal virulence trait of STEC is their ability to produce Shiga toxins. Systemic host injury is the likely consequence of toxemia, as STEC rarely invade extraintestinal sites or the bloodstream. Many serotypes of <em>E. coli</em> have genes encoding Shiga toxins 1 and/or 2, but a limited number of serotypes account for most human STEC isolates (<a class="graphic graphic_table graphicRef120224" href="/z/d/graphic/120224.html" rel="external">table 1</a>). </p><p>Shiga toxins 1 and 2 each have multiple allelic variants. In this topic, we refer to the Shiga toxin 1 and Shiga toxin 2 families, not a specific allele. Shiga toxin 1 is highly homologous to the principal extracellular cytotoxin of <em>S. dysenteriae</em> serotype 1; Shiga toxin 2 has 58 percent homology at the amino acid level to Shiga toxin 1 [<a href="#rid21">21</a>]. Shiga toxin 2 is more potent and much more frequently associated with severe human disease than Shiga toxin 1. (See <a class="local">'Shiga toxin type'</a> above.)</p><p>Shiga toxins have an AB<sub>5 </sub>subunit structure, with a pentameric B subunit that binds a sphingolipid, globotriaosylceramide (GB<sub>3</sub>), on eukaryotic cell surfaces, and an enzymatically active A subunit that enters the cell. Shiga toxins are N-glycosidases and inhibit protein synthesis in eukaryotic cells; their structure and mechanism of action resemble those of ricin [<a href="#rid22">22</a>]. A variety of interventions directed at Shiga toxins have been investigated, including those that neutralize circulating toxin and those that attenuate the effects of the internalized toxin, but none have advanced to clinical practice [<a href="#rid23">23,24</a>].</p><p>Toxemia has been thought to be a short-lived event early in STEC illness [<a href="#rid25">25</a>], though some data suggest toxin circulation later in illness [<a href="#rid26">26,27</a>]. Moreover, the concentrations of <em>E. coli</em> O157:H7 and free Shiga toxin in patients' stools generally diminish in the days following presentation [<a href="#rid28">28</a>].</p><p>Host injury is probably the consequence of systemic toxin-mediated microangiopathic injury. (See <a class="local">'Hemolytic uremic syndrome'</a> below.)</p><p class="headingAnchor" id="H2042160634"><span class="h2">Other virulence factors</span><span class="headingEndMark"> — </span>Extensive study of the genomes of <em>E. coli</em> O157:H7 demonstrates multiple virulence loci in addition to Shiga toxin [<a href="#rid29">29,30</a>].</p><p><em>E. coli</em> O157:H7 possess a gene encoding intimin, which is located on the locus of enterocyte effacement and is the principal adhesin of <em>E. coli</em> O157:H7 [<a href="#rid31">31</a>]. </p><p>The <em>E. coli</em> O157:H7 genome also encodes other adherence factors [<a href="#rid32">32</a>] and the enterohemorrhagic <em>E. coli</em> (EHEC)-hemolysin (a pore-forming toxin encoded on a large plasmid termed pO157) [<a href="#rid33">33</a>]. <em>E. coli</em> O157:H7 also form outer membrane vesicles that deliver virulence factors to host cells [<a href="#rid34">34</a>]. </p><p>Non-O157:H7 STEC contain, by definition, genes encoding Shiga toxin 1 and/or 2 and a variable set of virulence factors, some of which are shared with <em>E. coli</em> O157:H7. However, from a clinical standpoint, the only relevant issue is whether or not Shiga toxin 2 is present. (See <a class="local">'Shiga toxin type'</a> above.)</p><p class="headingAnchor" id="H816610594"><span class="h2">Hemolytic uremic syndrome</span><span class="headingEndMark"> — </span>Current understanding of pathogenesis suggests that systemic host injury is the consequence of circulating Shiga toxins, as STEC rarely invade extraintestinal organs or the bloodstream. </p><p>Toxin-mediated microangiopathic injury leads to a prothrombotic state in the human host, manifest by the formation of intravascular microthrombi. The prothrombotic abnormalities consist of elevated circulating activity of plasminogen activator-inhibitor type 1; elevated concentrations of circulating d-dimers, prothrombin activation fragment 1 + 2 [<a href="#rid35">35</a>], platelet activating factor [<a href="#rid36">36</a>], sheared Von Willebrand Factor [<a href="#rid37">37</a>], and chemokine ligand stromal cell-derived factor-1 [<a href="#rid38">38</a>]; and dysregulated angiopoietin 1 and 2 [<a href="#rid39">39</a>]. Intravascular microthrombi, if extensive, can cause acute kidney injury by critically occluding afferent renal vessels (<a class="graphic graphic_picture graphicRef68492" href="/z/d/graphic/68492.html" rel="external">picture 1</a>). The working hypothesis is that the prothrombotic state that exists at the time of presentation with an infection caused by a high-risk STEC precedes and can lead to the hemolytic uremic syndrome (HUS), a complication that develops in approximately 15 to 20 percent of <em>E. coli</em> O157:H7-infected children. (See  <a class="medical medical_review" href="/z/d/html/6081.html" rel="external">"Clinical manifestations and diagnosis of Shiga toxin-producing Escherichia coli (STEC) hemolytic uremic syndrome in children", section on 'Kidney pathology'</a>.)</p><p>These vascular derangements are also present, though usually to lesser extents, in children whose STEC infections do not progress to HUS.</p><p>There is no credible clinical evidence that STEC-related or treatable abnormalities in complement regulatory systems cause HUS following STEC infections [<a href="#rid40">40-43</a>] or that HUS and thrombotic thrombocytopenic purpura share a common pathophysiology [<a href="#rid37">37</a>].</p><p class="headingAnchor" id="H1358006436"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H2889758870"><span class="h2">Burden of disease</span><span class="headingEndMark"> — </span>STEC are important causes of diarrheal illness globally, mostly because of the severity of the illnesses they cause rather than the absolute number of people they infect. Reliable data from all parts of the world are limited, but in a review of studies and databases from 10 of 14 World Health Organization subregions, the global incidence of STEC infection was estimated at 2.8 million cases per year [<a href="#rid44">44</a>].</p><p>In the United States, the Centers for Disease Control and Prevention (CDC) <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Ffoodnet%2Freports%2Findex.html&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLP%2F2QvaEIA4SKO0gOEuf1VgY0YkeS8eQxq4ypPiI8NSzyeT%2FmnPtuFxMsoc8brVKag%3D%3D&amp;TOPIC_ID=2711" target="_blank">FoodNet</a> project reports the frequency of laboratory-confirmed causes of acute foodborne illnesses based on data collected from 10 sites. During 2022, the incidence of STEC infection was 5.7 cases per 100,000 persons, an increase from 5.3 cases per 100,000 in 2016 to 2018 [<a href="#rid45">45</a>].</p><p>The rank order of the four serogroups most frequently recovered from all patients are <em>E. coli</em> O26, O80, O157, and O145 (Europe); O157 (83.7 percent), O111 (5.9 percent), O145 (3.9 percent), O121 (2.5 percent; United States) [<a href="#rid46">46</a>], and O157 (73.6 percent), O145 (16.8 percent), O121 (5.4 percent), and O26 and O103 (tied; Argentina) [<a href="#rid47">47</a>].</p><p>STEC O157:H7 infection has been reported more frequently in the northern regions of the United States [<a href="#rid48">48</a>]. The reasons for this difference might include variations in detection and reporting of infected people and possibly proximity to cattle, which are termed "super shedders" because they excrete abundant <em>E. coli</em> O157:H7 [<a href="#rid49">49</a>]. Most <em>E. coli</em> O157:H7 infections occur between June and September. Notably, cattle shed <em>E. coli</em> O157:H7 mostly during the summer [<a href="#rid50">50</a>], and this seasonality correlates with higher prevalence of the organism on hides in processing plants [<a href="#rid51">51</a>]. </p><p class="headingAnchor" id="H1245145592"><span class="h2">Affected age groups</span><span class="headingEndMark"> — </span>STEC infection occurs in patients of all ages. About one-third of <em>E. coli</em> O157:H7 infections occur in patients 20 to 59 years old [<a href="#rid16">16</a>]. However, the greatest burden of hemolytic uremic syndrome (HUS) occurs in children &lt;5 years of age, followed by adults &gt;60 years old [<a href="#rid16">16,52-54</a>]. The reasons why these age groups are most commonly and severely affected are unknown, but potential explanations include exposure, transmission, the ability of specific strains to establish disease in specific populations, age-specific expression on cells of receptors for toxins, and diameters of renal blood vessels. </p><p>The median ages of patients infected with non-O157:H7 and O157:H7 STEC are similar [<a href="#rid55">55</a>].</p><p class="headingAnchor" id="H1428852634"><span class="h2">Transmission</span><span class="headingEndMark"> — </span>Transmission of STEC is primarily through food and person-to-person or animal contact. Vegetables (18 percent), animal (11 percent), person to person (9 percent), beef (6 percent), and water (5 percent) exposures are the most common sources of <em>E. coli</em> O157:H7 infections acquired in outbreaks. For non-O157:H7 outbreaks, the corresponding exposures are person to person (20 percent), vegetables grown in rows (9 percent), animal (5 percent), and water (2 percent); beef accounted for only 1 percent of outbreaks [<a href="#rid56">56</a>].</p><p class="headingAnchor" id="H244389791"><span class="h3">Foodborne</span><span class="headingEndMark"> — </span>The proportion of STEC outbreaks associated with consumption of beef has decreased [<a href="#rid57">57</a>], and the number of outbreaks caused by non-beef food products has risen and include fresh produce (eg, spinach, lettuce, ready-to-eat salads, fruit, sprouts) [<a href="#rid58">58-63</a>], other uncooked or unpasteurized products (such as raw milk, raw flour, raw dough [both prepackaged and homemade]), apple juice, soy nut butter, and falafel [<a href="#rid64">64-68</a>]. Non-beef meats, in particular pork and pork products, cause only a small portion of STEC outbreaks [<a href="#rid69">69</a>].</p><p>The most common reservoir for <em>E. coli</em> O157:H7 is the gastrointestinal tract of cattle, and beef is contaminated when the intestinal contents from a colonized animal contaminate the meat during harvest. Other ruminants, such as sheep, goats, and deer, carry <em>E. coli</em> O157:H7 in their gastrointestinal tracts and are potential sources of infection [<a href="#rid70">70</a>], and swine can also harbor and shed <em>E. coli</em> O157:H7 [<a href="#rid71">71</a>], but pork is rarely incriminated as an outbreak vehicle. Other food items and water can become contaminated when they encounter the feces of colonized animals.</p><p>In the United States, detailed information on current and recent outbreaks linked to specific food products can be found on the CDC <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fecoli%2Foutbreaks.html&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLA8tf2cyvXtbrXs87JiZIU%2BuCVrIotkiy9UbKdOiqHeBrwC1JCwUsNIWoeWxLU0oqw%3D%3D&amp;TOPIC_ID=2711" target="_blank">website</a> on <em>E. coli</em> outbreak investigations. Additional information is available from the US Food and Drug administration <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Ffood%2Frecalls-outbreaks-emergencies%2Foutbreaks-foodborne-illness&amp;token=RnGqCfYGTGgdz5387EFWwvy4g0FBsVH2%2F8GNTYjMB5LrJLowNdHBE3AHH5VQdHvjZEGstInrU%2FzZFkdijUOFBBVMo%2FciHvaLQZ9RU37rpBQ%3D&amp;TOPIC_ID=2711" target="_blank">website</a>.</p><p class="headingAnchor" id="H1164666215"><span class="h3">Animal contact</span><span class="headingEndMark"> — </span>STEC outbreaks have been associated with occupational exposure to animals, as well as recreational contact at county fairs, farms, and petting zoos, particularly in association with poor hand hygiene [<a href="#rid72">72-77</a>]. In a review of 55 outbreaks of enteric infection associated with animal contact in public settings, <em>E. coli</em> O157:H7 accounted for 58 percent [<a href="#rid74">74</a>]. </p><p>Investigation of an outbreak of <em>E. coli</em> O111 in a Colorado prison suggested that inmates were infected through fecally contaminated clothing and other items that were brought into food preparation areas by inmates who were employed at an onsite dairy and had extensive cattle contact [<a href="#rid78">78</a>]. This report highlights the importance of infection control measures during and after occupational animal contact, such as personal protective wear, thorough hygiene practices, and implementation of workflow patterns with discrete contaminated and clean areas. </p><p class="headingAnchor" id="H3176218811"><span class="h3">Person-to-person</span><span class="headingEndMark"> — </span>The low infectious dose of <em>E. coli</em> O157:H7 facilitates person-to-person transmission. Household and daycare contacts of STEC-infected patients are at particular risk and should seek medical care if they develop diarrhea. Secondary attack rates in outbreaks have ranged from 10 to 22 percent, particularly among children and adults in daycare centers and nursing homes [<a href="#rid79">79,80</a>], and households [<a href="#rid81">81</a>]. Hospitalization of STEC-infected patients has been proposed to reduce secondary infections in the community [<a href="#rid82">82</a>].</p><p>Person-to-person transmission of a non-O157:H7 STEC infection through fecal microbiota transplant has been reported; the pathogen was transmitted through stool from a single donor that tested negative for Shiga toxin by enzyme immunoassay (EIA) but was subsequently found to be positive for a Shiga toxin gene by polymerase chain reaction (PCR) [<a href="#rid83">83</a>]. In the United States, the Food and Drug Administration recommends that all stool donated for fecal microbiota transplantation be screened for STEC with Shiga toxin molecular testing [<a href="#rid84">84</a>]. (See  <a class="medical medical_review" href="/z/d/html/2604.html" rel="external">"Fecal microbiota transplantation for treatment of <i>Clostridioides difficile</i> infection", section on 'Stool donor selection'</a>.)</p><p class="headingAnchor" id="H2337177133"><span class="h2">Risk factors for sporadic cases</span><span class="headingEndMark"> — </span>It is important to note that most STEC infections are sporadic, ie, they cannot be linked to an identifiable outbreak. A prospective case-control study evaluating children with sporadic bacterial diarrhea identified domestic travel, home septic systems, recreational water exposure, and consumption of food from self-serve buffets, mobile stands, or table-service restaurants as risk factors for <em>E. coli</em> O157:H7 infection [<a href="#rid85">85</a>].</p><p>Other studies have identified proximity to livestock, rural residence, and water (private supply) [<a href="#rid86">86,87</a>].</p><p>Residing in a rural area increases the risk for <em>E. coli</em> O157:H7 infection [<a href="#rid88">88,89</a>]. It is plausible that this increased risk is related to environmental transmission. <em>E. coli</em> O157:H7 can persist within cattle farms and spread to neighboring farms [<a href="#rid90">90,91</a>]. Geogenomic trends suggest clusters of related STEC infections over time, which likely arise from a common, persistent environmental reservoir [<a href="#rid92">92</a>]. </p><p>Exposures to private water supplies, international travel, farm animals, raw sausage, and beef [<a href="#rid87">87,93,94</a>] have been proposed to be sources of sporadic non-O157:H7 STEC infections, though the literature is less extensive than for sporadic <em>E. coli</em> O157:H7 infections.</p><p class="headingAnchor" id="H1988736318"><span class="h1">PREVENTION</span><span class="headingEndMark"> — </span>STEC infection is primarily prevented through exposure reduction. Food safety measures to reduce exposure include proper handling of raw beef and meats and cooking ground meats to internal temperatures of ≥160°F (71°C) (<a class="graphic graphic_table graphicRef60529" href="/z/d/graphic/60529.html" rel="external">table 2</a>).</p><p>Individuals should also avoid consuming raw milk or other unpasteurized dairy and juice products, raw flour or dough, and other foods that are implicated in ongoing outbreaks. In the United States, information on specific outbreaks can be found on the Centers for Disease Control and Prevention <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fecoli%2Foutbreaks.html&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLA8tf2cyvXtbrXs87JiZIU%2BuCVrIotkiy9UbKdOiqHeBrwC1JCwUsNIWoeWxLU0oqw%3D%3D&amp;TOPIC_ID=2711" target="_blank">website</a> on <em>E. coli</em> outbreak investigations. </p><p>Hand hygiene is also thought to reduce transmission. Most individuals shed STEC for seven days or less, although occasional individuals, particularly younger children, shed the organism for three weeks or longer [<a href="#rid82">82,95-98</a>]. </p><p>Infection control measures for hospitalized patients and public health considerations are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2714.html" rel="external">"Shiga toxin-producing Escherichia coli: Clinical manifestations, diagnosis, and treatment", section on 'Infection control measures'</a>.)</p><p class="headingAnchor" id="H3950559672"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/109942.html" rel="external">"Society guideline links: Acute diarrhea in adults"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/110029.html" rel="external">"Society guideline links: Acute diarrhea in children"</a>.)</p><p class="headingAnchor" id="H339587366"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/86006.html" rel="external">"Patient education: E. coli diarrhea (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H3067903275"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Shiga toxin-producing <em>Escherichia coli</em> (STEC) cause serious disease characterized by bloody diarrhea; hemolytic uremic syndrome (HUS) is the major complication. Those that contain a gene encoding Shiga toxin 2 are more virulent (<a class="graphic graphic_table graphicRef120224" href="/z/d/graphic/120224.html" rel="external">table 1</a>). (See <a class="local">'Shiga toxin type'</a> above and <a class="local">'Toxin production'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>E. coli</em> strains can be classified by their O and H antigens into serotypes. <em>E. coli</em> O157:H7 is the most important STEC serotype in much of the world. It has been the most commonly isolated serotype and the leading cause of HUS, though data from Europe demonstrate that <em>E. coli</em> O26 is an increasingly common cause of HUS. Infections due to non-O157:H7 serotypes are increasingly recognized. (See <a class="local">'Serotypes'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The greatest burden of severe STEC infection and HUS occurs in children &lt;5 years of age, followed by adults &gt;60 years old. (See <a class="local">'Affected age groups'</a> above and <a class="local">'Burden of disease'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The most common route of transmission is foodborne; transmission also occurs through contact with colonized animals, infected individuals, and contaminated water. Beef has traditionally been the most common source of foodborne outbreaks, but many non-beef food products have also been implicated in STEC outbreaks. These mainly include fresh produce and other uncooked or unpasteurized products. (See <a class="local">'Transmission'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>STEC infection is primarily prevented through exposure reduction. Preventive strategies include cooking beef and other meats adequately; avoiding consumption of unpasteurized dairy and juice products, raw flour or dough, and other foods that are implicated in outbreaks; and using proper hand hygiene. (See <a class="local">'Prevention'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Riley LW, Remis RS, Helgerson SD, et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 1983; 308:681.</a></li><li><a class="nounderline abstract_t">Karmali MA, Steele BT, Petric M, Lim C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 1983; 1:619.</a></li><li><a class="nounderline abstract_t">Calderwood SB, Acheson DWK, Keusch GT, et al. Proposed new nomenclature for SLT (VT) family. ASM News 1996; 62:118.</a></li><li><a class="nounderline abstract_t">Clogher P, Hurd S, Hoefer D, et al. Assessment of physician knowledge and practices concerning Shiga toxin-producing Escherichia coli infection and enteric illness, 2009, Foodborne Diseases Active Surveillance Network (FoodNet). Clin Infect Dis 2012; 54 Suppl 5:S446.</a></li><li class="breakAll">Kozyreva VK, Jospin G, Greninger AL, et al. Recent Outbreaks of Shigellosis in California Caused by Two Distinct Populations of Shigella sonnei with either Increased Virulence or Fluoroquinolone Resistance. mSphere 2016; 1.</li><li><a class="nounderline abstract_t">Nyholm O, Lienemann T, Halkilahti J, et al. Characterization of Shigella sonnei Isolate Carrying Shiga Toxin 2-Producing Gene. Emerg Infect Dis 2015; 21:891.</a></li><li><a class="nounderline abstract_t">Gray MD, Lampel KA, Strockbine NA, et al. Clinical isolates of Shiga toxin 1a-producing Shigella flexneri with an epidemiological link to recent travel to Hispañiola. Emerg Infect Dis 2014; 20:1669.</a></li><li><a class="nounderline abstract_t">Sváb D, Bálint B, Vásárhelyi B, et al. Comparative Genomic and Phylogenetic Analysis of a Shiga Toxin Producing Shigella sonnei (STSS) Strain. Front Cell Infect Microbiol 2017; 7:229.</a></li><li><a class="nounderline abstract_t">Karch H, Bielaszewska M. Sorbitol-fermenting Shiga toxin-producing Escherichia coli O157:H(-) strains: epidemiology, phenotypic and molecular characteristics, and microbiological diagnosis. J Clin Microbiol 2001; 39:2043.</a></li><li><a class="nounderline abstract_t">Anderson NW, Tarr PI. Multiplex Nucleic Acid Amplification Testing to Diagnose Gut Infections: Challenges, Opportunities, and Result Interpretation. Gastroenterol Clin North Am 2018; 47:793.</a></li><li><a class="nounderline abstract_t">Zelyas N, Poon A, Patterson-Fortin L, et al. Assessment of commercial chromogenic solid media for the detection of non-O157 Shiga toxin-producing Escherichia coli (STEC). Diagn Microbiol Infect Dis 2016; 85:302.</a></li><li><a class="nounderline abstract_t">Slutsker L, Ries AA, Greene KD, et al. Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features. Ann Intern Med 1997; 126:505.</a></li><li><a class="nounderline abstract_t">Jelacic JK, Damrow T, Chen GS, et al. Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles. J Infect Dis 2003; 188:719.</a></li><li><a class="nounderline abstract_t">Jelacic S, Wobbe CL, Boster DR, et al. ABO and P1 blood group antigen expression and stx genotype and outcome of childhood Escherichia coli O157:H7 infections. J Infect Dis 2002; 185:214.</a></li><li><a class="nounderline abstract_t">Ostroff SM, Tarr PI, Neill MA, et al. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J Infect Dis 1989; 160:994.</a></li><li><a class="nounderline abstract_t">Tarr GAM, Shringi S, Oltean HN, et al. Importance of case age in the purported association between phylogenetics and hemolytic uremic syndrome in Escherichia coli O157:H7 infections. Epidemiol Infect 2018; 146:1550.</a></li><li><a class="nounderline abstract_t">Tarr GAM, Stokowski T, Shringi S, et al. Contribution and Interaction of Shiga Toxin Genes to Escherichia coli O157:H7 Virulence. Toxins (Basel) 2019; 11.</a></li><li><a class="nounderline abstract_t">Ardissino G, Possenti I, Vignati C, et al. Is Shigatoxin 1 protective for the development of Shigatoxin 2-related hemolytic uremic syndrome in children? Data from the ItalKid-HUS Network. Pediatr Nephrol 2020; 35:1997.</a></li><li><a class="nounderline abstract_t">Luna-Gierke RE, Wymore K, Sadlowski J, et al. Multiple-aetiology enteric infections involving non-O157 Shiga toxin-producing Escherichia coli--FoodNet, 2001-2010. Zoonoses Public Health 2014; 61:492.</a></li><li><a class="nounderline abstract_t">Tilden J Jr, Young W, McNamara AM, et al. A new route of transmission for Escherichia coli: infection from dry fermented salami. Am J Public Health 1996; 86:1142.</a></li><li><a class="nounderline abstract_t">Jackson MP, Neill RJ, O'Brien AD, et al. Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages from Escherichia coli 933. FEMS Microbiol Lett 1987; 44:109.</a></li><li><a class="nounderline abstract_t">Melton-Celsa AR. Shiga Toxin (Stx) Classification, Structure, and Function. Microbiol Spectr 2014; 2:EHEC.</a></li><li class="breakAll">Hall G, Kurosawa S, Stearns-Kurosawa DJ. Shiga Toxin Therapeutics: Beyond Neutralization. Toxins (Basel) 2017;9.</li><li><a class="nounderline abstract_t">Melton-Celsa AR, O'Brien AD. New Therapeutic Developments against Shiga Toxin-Producing Escherichia coli. Microbiol Spectr 2014; 2.</a></li><li><a class="nounderline abstract_t">López EL, Contrini MM, Glatstein E, et al. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values. Pediatr Infect Dis J 2012; 31:20.</a></li><li><a class="nounderline abstract_t">Ståhl AL, Arvidsson I, Johansson KE, et al. A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles. PLoS Pathog 2015; 11:e1004619.</a></li><li><a class="nounderline abstract_t">Brigotti M, He X, Carnicelli D, et al. Particulate Shiga Toxin 2 in Blood is Associated to the Development of Hemolytic Uremic Syndrome in Children. Thromb Haemost 2020; 120:107.</a></li><li><a class="nounderline abstract_t">Cornick NA, Jelacic S, Ciol MA, Tarr PI. Escherichia coli O157:H7 infections: discordance between filterable fecal shiga toxin and disease outcome. J Infect Dis 2002; 186:57.</a></li><li><a class="nounderline abstract_t">Perna NT, Plunkett G 3rd, Burland V, et al. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 2001; 409:529.</a></li><li><a class="nounderline abstract_t">Hayashi T, Makino K, Ohnishi M, et al. Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. DNA Res 2001; 8:11.</a></li><li><a class="nounderline abstract_t">Stevens MP, Frankel GM. The Locus of Enterocyte Effacement and Associated Virulence Factors of Enterohemorrhagic Escherichia coli. Microbiol Spectr 2014; 2:EHEC.</a></li><li><a class="nounderline abstract_t">McWilliams BD, Torres AG. EHEC Adhesins. Microbiol Spectr 2014; 2:EHEC00032013.</a></li><li><a class="nounderline abstract_t">Bielaszewska M, Aldick T, Bauwens A, Karch H. Hemolysin of enterohemorrhagic Escherichia coli: structure, transport, biological activity and putative role in virulence. Int J Med Microbiol 2014; 304:521.</a></li><li><a class="nounderline abstract_t">Bielaszewska M, Rüter C, Bauwens A, et al. Host cell interactions of outer membrane vesicle-associated virulence factors of enterohemorrhagic Escherichia coli O157: Intracellular delivery, trafficking and mechanisms of cell injury. PLoS Pathog 2017; 13:e1006159.</a></li><li><a class="nounderline abstract_t">Chandler WL, Jelacic S, Boster DR, et al. Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome. N Engl J Med 2002; 346:23.</a></li><li><a class="nounderline abstract_t">Smith JM, Jones F, Ciol MA, et al. Platelet-activating factor and Escherichia coliO157:H7 infections. Pediatr Nephrol 2002; 17:1047.</a></li><li><a class="nounderline abstract_t">Tsai HM, Chandler WL, Sarode R, et al. von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatr Res 2001; 49:653.</a></li><li><a class="nounderline abstract_t">Petruzziello-Pellegrini TN, Yuen DA, Page AV, et al. The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice. J Clin Invest 2012; 122:759.</a></li><li><a class="nounderline abstract_t">Page AV, Tarr PI, Watkins SL, et al. Dysregulation of angiopoietin 1 and 2 in Escherichia coli O157:H7 infection and the hemolytic-uremic syndrome. J Infect Dis 2013; 208:929.</a></li><li><a class="nounderline abstract_t">Kielstein JT, Beutel G, Fleig S, et al. Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry. Nephrol Dial Transplant 2012; 27:3807.</a></li><li><a class="nounderline abstract_t">Menne J, Nitschke M, Stingele R, et al. Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ 2012; 345:e4565.</a></li><li><a class="nounderline abstract_t">Porubsky S, Federico G, Müthing J, et al. Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure. J Pathol 2014; 234:120.</a></li><li><a class="nounderline abstract_t">Samuelsson O, Follin P, Rundgren M, et al. [The HUS epidemic in the summer of 2011 was severe. German and Swedish experiences of the EHEC outbreak]. Lakartidningen 2012; 109:1230.</a></li><li><a class="nounderline abstract_t">Majowicz SE, Scallan E, Jones-Bitton A, et al. Global incidence of human Shiga toxin-producing Escherichia coli infections and deaths: a systematic review and knowledge synthesis. Foodborne Pathog Dis 2014; 11:447.</a></li><li><a class="nounderline abstract_t">Delahoy MJ, Shah HJ, Weller DL, et al. Preliminary Incidence and Trends of Infections Caused by Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2022. MMWR Morb Mortal Wkly Rep 2023; 72:701.</a></li><li class="breakAll">Centers for Disease Control and Prevention. FoodNet Fast. https://wwwn.cdc.gov/foodnetfast/ (Accessed on November 21, 2022).</li><li><a class="nounderline abstract_t">Alconcher LF, Balestracci A, Coccia PA, et al. Hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli infection in Argentina: update of serotypes and genotypes and their relationship with severity of the disease. Pediatr Nephrol 2021; 36:2811.</a></li><li><a class="nounderline abstract_t">Sodha SV, Heiman K, Gould LH, et al. National patterns of Escherichia coli O157 infections, USA, 1996-2011. Epidemiol Infect 2015; 143:267.</a></li><li><a class="nounderline abstract_t">Chase-Topping M, Gally D, Low C, et al. Super-shedding and the link between human infection and livestock carriage of Escherichia coli O157. Nat Rev Microbiol 2008; 6:904.</a></li><li><a class="nounderline abstract_t">Hancock DD, Besser TE, Rice DH, et al. A longitudinal study of Escherichia coli O157 in fourteen cattle herds. Epidemiol Infect 1997; 118:193.</a></li><li><a class="nounderline abstract_t">Barkocy-Gallagher GA, Arthur TM, Rivera-Betancourt M, et al. Seasonal prevalence of Shiga toxin-producing Escherichia coli, including O157:H7 and non-O157 serotypes, and Salmonella in commercial beef processing plants. J Food Prot 2003; 66:1978.</a></li><li><a class="nounderline abstract_t">Marder Mph EP, Griffin PM, Cieslak PR, et al. Preliminary Incidence and Trends of Infections with Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2006-2017. MMWR Morb Mortal Wkly Rep 2018; 67:324.</a></li><li><a class="nounderline abstract_t">Crim SM, Iwamoto M, Huang JY, et al. Incidence and trends of infection with pathogens transmitted commonly through food--Foodborne Diseases Active Surveillance Network, 10 U.S. sites, 2006-2013. MMWR Morb Mortal Wkly Rep 2014; 63:328.</a></li><li><a class="nounderline abstract_t">Crim SM, Griffin PM, Tauxe R, et al. Preliminary incidence and trends of infection with pathogens transmitted commonly through food - Foodborne Diseases Active Surveillance Network, 10 U.S. sites, 2006-2014. MMWR Morb Mortal Wkly Rep 2015; 64:495.</a></li><li><a class="nounderline abstract_t">Gould LH, Mody RK, Ong KL, et al. Increased recognition of non-O157 Shiga toxin-producing Escherichia coli infections in the United States during 2000-2010: epidemiologic features and comparison with E. coli O157 infections. Foodborne Pathog Dis 2013; 10:453.</a></li><li><a class="nounderline abstract_t">Tack DM, Kisselburgh HM, Richardson LC, et al. Shiga Toxin-Producing Escherichia coli Outbreaks in the United States, 2010-2017. Microorganisms 2021; 9.</a></li><li><a class="nounderline abstract_t">Heiman KE, Mody RK, Johnson SD, et al. Escherichia coli O157 Outbreaks in the United States, 2003-2012. Emerg Infect Dis 2015; 21:1293.</a></li><li><a class="nounderline abstract_t">Fukushima H, Hashizume T, Morita Y, et al. Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai City, 1996. Pediatr Int 1999; 41:213.</a></li><li><a class="nounderline abstract_t">Laidler MR, Tourdjman M, Buser GL, et al. Escherichia coli O157:H7 infections associated with consumption of locally grown strawberries contaminated by deer. Clin Infect Dis 2013; 57:1129.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Ongoing multistate outbreak of Escherichia coli serotype O157:H7 infections associated with consumption of fresh spinach--United States, September 2006. MMWR Morb Mortal Wkly Rep 2006; 55:1045.</a></li><li><a class="nounderline abstract_t">Buchholz U, Bernard H, Werber D, et al. German outbreak of Escherichia coli O104:H4 associated with sprouts. N Engl J Med 2011; 365:1763.</a></li><li><a class="nounderline abstract_t">King LA, Nogareda F, Weill FX, et al. Outbreak of Shiga toxin-producing Escherichia coli O104:H4 associated with organic fenugreek sprouts, France, June 2011. Clin Infect Dis 2012; 54:1588.</a></li><li><a class="nounderline abstract_t">Bottichio L, Keaton A, Thomas D, et al. Shiga Toxin-Producing Escherichia coli Infections Associated With Romaine Lettuce-United States, 2018. Clin Infect Dis 2020; 71:e323.</a></li><li class="breakAll">Centers for Disease Control and Prevention. E. coli Outbreak Linked to Frozen Falafel. https://www.cdc.gov/ecoli/2022/o121-10-22/index.html (Accessed on December 05, 2022).</li><li><a class="nounderline abstract_t">Guh A, Phan Q, Nelson R, et al. Outbreak of Escherichia coli O157 associated with raw milk, Connecticut, 2008. Clin Infect Dis 2010; 51:1411.</a></li><li><a class="nounderline abstract_t">Neil KP, Biggerstaff G, MacDonald JK, et al. A novel vehicle for transmission of Escherichia coli O157:H7 to humans: multistate outbreak of E. coli O157:H7 infections associated with consumption of ready-to-bake commercial prepackaged cookie dough--United States, 2009. Clin Infect Dis 2012; 54:511.</a></li><li class="breakAll">United States Centers for Disease Control and Prevention. Multistate Outbreak of Shiga toxin-producing Escherichia coli O157:H7 Infections Linked to I.M. Healthy Brand Soy Nut Butter https://www.cdc.gov/ecoli/2017/o157h7-03-17/index.html (Accessed on March 06, 2017).</li><li><a class="nounderline abstract_t">Crowe SJ, Bottichio L, Shade LN, et al. Shiga Toxin-Producing E. coli Infections Associated with Flour. N Engl J Med 2017; 377:2036.</a></li><li><a class="nounderline abstract_t">Honish L, Punja N, Nunn S, et al. Escherichia coli O157:H7 Infections Associated with Contaminated Pork Products - Alberta, Canada, July-October 2014. MMWR Morb Mortal Wkly Rep 2017; 65:1477.</a></li><li><a class="nounderline abstract_t">La Ragione RM, Best A, Woodward MJ, Wales AD. Escherichia coli O157:H7 colonization in small domestic ruminants. FEMS Microbiol Rev 2009; 33:394.</a></li><li><a class="nounderline abstract_t">Tseng M, Fratamico PM, Manning SD, Funk JA. Shiga toxin-producing Escherichia coli in swine: the public health perspective. Anim Health Res Rev 2014; 15:63.</a></li><li><a class="nounderline abstract_t">Crump JA, Sulka AC, Langer AJ, et al. An outbreak of Escherichia coli O157:H7 infections among visitors to a dairy farm. N Engl J Med 2002; 347:555.</a></li><li><a class="nounderline abstract_t">Varma JK, Greene KD, Reller ME, et al. An outbreak of Escherichia coli O157 infection following exposure to a contaminated building. JAMA 2003; 290:2709.</a></li><li><a class="nounderline abstract_t">Steinmuller N, Demma L, Bender JB, et al. Outbreaks of enteric disease associated with animal contact: not just a foodborne problem anymore. Clin Infect Dis 2006; 43:1596.</a></li><li><a class="nounderline abstract_t">Weese JS, McCarthy L, Mossop M, et al. Observation of practices at petting zoos and the potential impact on zoonotic disease transmission. Clin Infect Dis 2007; 45:10.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Notes from the field: Escherichia coli O157:H7 gastroenteritis associated with a State Fair - North Carolina, 2011. MMWR Morb Mortal Wkly Rep 2012; 60:1745.</a></li><li><a class="nounderline abstract_t">Laughlin M, Gambino-Shirley K, Gacek P, et al. Notes from the Field: Outbreak of Escherichia coli O157 Infections Associated with Goat Dairy Farm Visits - Connecticut, 2016. MMWR Morb Mortal Wkly Rep 2016; 65:1453.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Outbreak of Shiga toxin-producing Escherichia coli O111 infections associated with a correctional facility dairy - Colorado, 2010. MMWR Morb Mortal Wkly Rep 2012; 61:149.</a></li><li><a class="nounderline abstract_t">Boyce TG, Swerdlow DL, Griffin PM. Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med 1995; 333:364.</a></li><li><a class="nounderline abstract_t">Raffaelli RM, Paladini M, Hanson H, et al. Child care-associated outbreak of Escherichia coli O157:H7 and hemolytic uremic syndrome. Pediatr Infect Dis J 2007; 26:951.</a></li><li><a class="nounderline abstract_t">Luini MV, Colombo R, Dodaro A, et al. Family Clusters of Shiga Toxin-producing Escherichia coli Infection: An Overlooked Source of Transmission. Data From the ItalKid-Hus Network. Pediatr Infect Dis J 2021; 40:1.</a></li><li><a class="nounderline abstract_t">Werber D, Mason BW, Evans MR, Salmon RL. Preventing household transmission of Shiga toxin-producing Escherichia coli O157 infection: promptly separating siblings might be the key. Clin Infect Dis 2008; 46:1189.</a></li><li><a class="nounderline abstract_t">Zellmer C, Sater MRA, Huntley MH, et al. Shiga Toxin-Producing Escherichia coli Transmission via Fecal Microbiota Transplant. Clin Infect Dis 2021; 72:e876.</a></li><li class="breakAll">https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/information-pertaining-additional-safety-protections-regarding-use-fecal-microbiota-transplantation-0 (Accessed on January 22, 2021).</li><li><a class="nounderline abstract_t">Denno DM, Keene WE, Hutter CM, et al. Tri-county comprehensive assessment of risk factors for sporadic reportable bacterial enteric infection in children. J Infect Dis 2009; 199:467.</a></li><li><a class="nounderline abstract_t">Elson R, Grace K, Vivancos R, et al. A spatial and temporal analysis of risk factors associated with sporadic Shiga toxin-producing Escherichia coli O157 infection in England between 2009 and 2015. Epidemiol Infect 2018; 146:1928.</a></li><li><a class="nounderline abstract_t">Óhaiseadha C, Hynds PD, Fallon UB, O'Dwyer J. A geostatistical investigation of agricultural and infrastructural risk factors associated with primary verotoxigenic E. coli (VTEC) infection in the Republic of Ireland, 2008-2013. Epidemiol Infect 2017; 145:95.</a></li><li><a class="nounderline abstract_t">Innocent GT, Mellor DJ, McEwen SA, et al. Spatial and temporal epidemiology of sporadic human cases of Escherichia coli O157 in Scotland, 1996-1999. Epidemiol Infect 2005; 133:1033.</a></li><li><a class="nounderline abstract_t">Haack JP, Jelacic S, Besser TE, et al. Escherichia coli O157 exposure in Wyoming and Seattle: serologic evidence of rural risk. Emerg Infect Dis 2003; 9:1226.</a></li><li><a class="nounderline abstract_t">Herbert LJ, Vali L, Hoyle DV, et al. E. coli O157 on Scottish cattle farms: evidence of local spread and persistence using repeat cross-sectional data. BMC Vet Res 2014; 10:95.</a></li><li><a class="nounderline abstract_t">Liebana E, Smith RP, Batchelor M, et al. Persistence of Escherichia coli O157 isolates on bovine farms in England and Wales. J Clin Microbiol 2005; 43:898.</a></li><li><a class="nounderline abstract_t">Tarr GAM, Shringi S, Phipps AI, et al. Geogenomic Segregation and Temporal Trends of Human Pathogenic Escherichia coli O157:H7, Washington, USA, 2005-20141. Emerg Infect Dis 2018; 24:32.</a></li><li><a class="nounderline abstract_t">Friesema IH, Schotsborg M, Heck ME, Van Pelt W. Risk factors for sporadic Shiga toxin-producing Escherichia coli O157 and non-O157 illness in The Netherlands, 2008-2012, using periodically surveyed controls. Epidemiol Infect 2015; 143:1360.</a></li><li><a class="nounderline abstract_t">Byrne L, Jenkins C, Launders N, et al. The epidemiology, microbiology and clinical impact of Shiga toxin-producing Escherichia coli in England, 2009-2012. Epidemiol Infect 2015; 143:3475.</a></li><li><a class="nounderline abstract_t">Wells JG, Davis BR, Wachsmuth IK, et al. Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype. J Clin Microbiol 1983; 18:512.</a></li><li><a class="nounderline abstract_t">Karch H, Rüssmann H, Schmidt H, et al. Long-term shedding and clonal turnover of enterohemorrhagic Escherichia coli O157 in diarrheal diseases. J Clin Microbiol 1995; 33:1602.</a></li><li><a class="nounderline abstract_t">Welinder-Olsson C, Kjellin E, Badenfors M, Kaijser B. Improved microbiological techniques using the polymerase chain reaction and pulsed-field gel electrophoresis for diagnosis and follow-up of enterohaemorrhagic Escherichia coli infection. Eur J Clin Microbiol Infect Dis 2000; 19:843.</a></li><li><a class="nounderline abstract_t">Seto EY, Soller JA, Colford JM Jr. Strategies to reduce person-to-person transmission during widespread Escherichia coli O157:H7 outbreak. Emerg Infect Dis 2007; 13:860.</a></li></ol></div><div id="topicVersionRevision">Topic 2711 Version 39.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6338386" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Hemorrhagic colitis associated with a rare Escherichia coli serotype.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6131302" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Proposed new nomenclature for SLT (VT) family</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22572668" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Assessment of physician knowledge and practices concerning Shiga toxin-producing Escherichia coli infection and enteric illness, 2009, Foodborne Diseases Active Surveillance Network (FoodNet).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22572668" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Assessment of physician knowledge and practices concerning Shiga toxin-producing Escherichia coli infection and enteric illness, 2009, Foodborne Diseases Active Surveillance Network (FoodNet).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25897522" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Characterization of Shigella sonnei Isolate Carrying Shiga Toxin 2-Producing Gene.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25271406" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Clinical isolates of Shiga toxin 1a-producing Shigella flexneri with an epidemiological link to recent travel to Hispañiola.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28611956" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Comparative Genomic and Phylogenetic Analysis of a Shiga Toxin Producing Shigella sonnei (STSS) Strain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11376032" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Sorbitol-fermenting Shiga toxin-producing Escherichia coli O157:H(-) strains: epidemiology, phenotypic and molecular characteristics, and microbiological diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30337033" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Multiplex Nucleic Acid Amplification Testing to Diagnose Gut Infections: Challenges, Opportunities, and Result Interpretation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27157987" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Assessment of commercial chromogenic solid media for the detection of non-O157 Shiga toxin-producing Escherichia coli (STEC).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9092315" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12934188" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11807695" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : ABO and P1 blood group antigen expression and stx genotype and outcome of childhood Escherichia coli O157:H7 infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2685131" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29914582" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Importance of case age in the purported association between phylogenetics and hemolytic uremic syndrome in Escherichia coli O157:H7 infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31635282" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Contribution and Interaction of Shiga Toxin Genes to Escherichia coli O157:H7 Virulence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32734345" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Is Shigatoxin 1 protective for the development of Shigatoxin 2-related hemolytic uremic syndrome in children? Data from the ItalKid-HUS Network.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24484079" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Multiple-aetiology enteric infections involving non-O157 Shiga toxin-producing Escherichia coli--FoodNet, 2001-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8712275" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : A new route of transmission for Escherichia coli: infection from dry fermented salami.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages from Escherichia coli 933</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25530917" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Shiga Toxin (Stx) Classification, Structure, and Function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25530917" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Shiga Toxin (Stx) Classification, Structure, and Function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26104346" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : New Therapeutic Developments against Shiga Toxin-Producing Escherichia coli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21829137" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25719452" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31858520" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Particulate Shiga Toxin 2 in Blood is Associated to the Development of Hemolytic Uremic Syndrome in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12089662" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Escherichia coli O157:H7 infections: discordance between filterable fecal shiga toxin and disease outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11206551" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Genome sequence of enterohaemorrhagic Escherichia coli O157:H7.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11258796" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26104209" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The Locus of Enterocyte Effacement and Associated Virulence Factors of Enterohemorrhagic Escherichia coli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25635238" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : EHEC Adhesins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24933303" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Hemolysin of enterohemorrhagic Escherichia coli: structure, transport, biological activity and putative role in virulence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28158302" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Host cell interactions of outer membrane vesicle-associated virulence factors of enterohemorrhagic Escherichia coli O157: Intracellular delivery, trafficking and mechanisms of cell injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11777999" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12478356" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Platelet-activating factor and Escherichia coliO157:H7 infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11328948" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22232208" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23801605" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Dysregulation of angiopoietin 1 and 2 in Escherichia coli O157:H7 infection and the hemolytic-uremic syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23114903" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22815429" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24909663" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22838113" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : [The HUS epidemic in the summer of 2011 was severe. German and Swedish experiences of the EHEC outbreak].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24750096" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Global incidence of human Shiga toxin-producing Escherichia coli infections and deaths: a systematic review and knowledge synthesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37384552" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Preliminary Incidence and Trends of Infections Caused by Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37384552" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Preliminary Incidence and Trends of Infections Caused by Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33604727" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli infection in Argentina: update of serotypes and genotypes and their relationship with severity of the disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24731294" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : National patterns of Escherichia coli O157 infections, USA, 1996-2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19008890" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Super-shedding and the link between human infection and livestock carriage of Escherichia coli O157.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9129597" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : A longitudinal study of Escherichia coli O157 in fourteen cattle herds.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14627272" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Seasonal prevalence of Shiga toxin-producing Escherichia coli, including O157:H7 and non-O157 serotypes, and Salmonella in commercial beef processing plants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29565841" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Preliminary Incidence and Trends of Infections with Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2006-2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24739341" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Incidence and trends of infection with pathogens transmitted commonly through food--Foodborne Diseases Active Surveillance Network, 10 U.S. sites, 2006-2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25974634" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Preliminary incidence and trends of infection with pathogens transmitted commonly through food - Foodborne Diseases Active Surveillance Network, 10 U.S. sites, 2006-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23560425" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Increased recognition of non-O157 Shiga toxin-producing Escherichia coli infections in the United States during 2000-2010: epidemiologic features and comparison with E. coli O157 infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34361964" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Shiga Toxin-Producing Escherichia coli Outbreaks in the United States, 2010-2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26197993" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Escherichia coli O157 Outbreaks in the United States, 2003-2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10221032" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai City, 1996.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23876397" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Escherichia coli O157:H7 infections associated with consumption of locally grown strawberries contaminated by deer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17008868" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Ongoing multistate outbreak of Escherichia coli serotype O157:H7 infections associated with consumption of fresh spinach--United States, September 2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22029753" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : German outbreak of Escherichia coli O104:H4 associated with sprouts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22460976" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Outbreak of Shiga toxin-producing Escherichia coli O104:H4 associated with organic fenugreek sprouts, France, June 2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31814028" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Shiga Toxin-Producing Escherichia coli Infections Associated With Romaine Lettuce-United States, 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31814028" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Shiga Toxin-Producing Escherichia coli Infections Associated With Romaine Lettuce-United States, 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21058911" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Outbreak of Escherichia coli O157 associated with raw milk, Connecticut, 2008.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22157169" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : A novel vehicle for transmission of Escherichia coli O157:H7 to humans: multistate outbreak of E. coli O157:H7 infections associated with consumption of ready-to-bake commercial prepackaged cookie dough--United States, 2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22157169" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : A novel vehicle for transmission of Escherichia coli O157:H7 to humans: multistate outbreak of E. coli O157:H7 infections associated with consumption of ready-to-bake commercial prepackaged cookie dough--United States, 2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29166238" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Shiga Toxin-Producing E. coli Infections Associated with Flour.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28056011" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Escherichia coli O157:H7 Infections Associated with Contaminated Pork Products - Alberta, Canada, July-October 2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19207740" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Escherichia coli O157:H7 colonization in small domestic ruminants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24397985" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Shiga toxin-producing Escherichia coli in swine: the public health perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12192014" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : An outbreak of Escherichia coli O157:H7 infections among visitors to a dairy farm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14645313" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : An outbreak of Escherichia coli O157 infection following exposure to a contaminated building.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17109295" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Outbreaks of enteric disease associated with animal contact: not just a foodborne problem anymore.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17554694" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Observation of practices at petting zoos and the potential impact on zoonotic disease transmission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22217625" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Notes from the field: Escherichia coli O157:H7 gastroenteritis associated with a State Fair - North Carolina, 2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28033314" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Notes from the Field: Outbreak of Escherichia coli O157 Infections Associated with Goat Dairy Farm Visits - Connecticut, 2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22398842" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Outbreak of Shiga toxin-producing Escherichia coli O111 infections associated with a correctional facility dairy - Colorado, 2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7609755" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Escherichia coli O157:H7 and the hemolytic-uremic syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17901803" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Child care-associated outbreak of Escherichia coli O157:H7 and hemolytic uremic syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32898091" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Family Clusters of Shiga Toxin-producing Escherichia coli Infection: An Overlooked Source of Transmission. Data From the ItalKid-Hus Network.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18444854" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Preventing household transmission of Shiga toxin-producing Escherichia coli O157 infection: promptly separating siblings might be the key.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33159210" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Shiga Toxin-Producing Escherichia coli Transmission via Fecal Microbiota Transplant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33159210" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Shiga Toxin-Producing Escherichia coli Transmission via Fecal Microbiota Transplant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19281302" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Tri-county comprehensive assessment of risk factors for sporadic reportable bacterial enteric infection in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30205851" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : A spatial and temporal analysis of risk factors associated with sporadic Shiga toxin-producing Escherichia coli O157 infection in England between 2009 and 2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27609320" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : A geostatistical investigation of agricultural and infrastructural risk factors associated with primary verotoxigenic E. coli (VTEC) infection in the Republic of Ireland, 2008-2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16274499" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Spatial and temporal epidemiology of sporadic human cases of Escherichia coli O157 in Scotland, 1996-1999.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14609456" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Escherichia coli O157 exposure in Wyoming and Seattle: serologic evidence of rural risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24766709" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : E. coli O157 on Scottish cattle farms: evidence of local spread and persistence using repeat cross-sectional data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15695700" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Persistence of Escherichia coli O157 isolates on bovine farms in England and Wales.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29260688" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Geogenomic Segregation and Temporal Trends of Human Pathogenic Escherichia coli O157:H7, Washington, USA, 2005-20141.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25195737" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Risk factors for sporadic Shiga toxin-producing Escherichia coli O157 and non-O157 illness in The Netherlands, 2008-2012, using periodically surveyed controls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25920912" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : The epidemiology, microbiology and clinical impact of Shiga toxin-producing Escherichia coli in England, 2009-2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6355145" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7650195" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Long-term shedding and clonal turnover of enterohemorrhagic Escherichia coli O157 in diarrheal diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11152309" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Improved microbiological techniques using the polymerase chain reaction and pulsed-field gel electrophoresis for diagnosis and follow-up of enterohaemorrhagic Escherichia coli infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17553224" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Strategies to reduce person-to-person transmission during widespread Escherichia coli O157:H7 outbreak.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
